Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.
Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.
"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."
Steve Schaefer
CEO, Mi-Helper, Inc.
VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration.
A global pharmaceutical company needed to understand the impact of a dissociative anesthetic on quality of life in patients with treatment-resistant depression. The company sought a way to gather high-quality data and carefully monitor suicidality.